The RhaS and RhaR proteins are transcription activators that respond to the availability of L-rhamnose 
INTRODUCTION
kan (from KM22) into SME1216 (selecting for kanamycin resistance) to make SME2417. SME2495 was made using P1 transduction to move D(rhaSR)::kan zih-35::Tn10 (from SME2800) in SME1217 selecting for tetracycline resistance and then screening for a Rha -phenotype. SME2496 was made from SME2416 by transformation with a PCR product containing D(rhaSR)::cat-sac (amplified from pSE254 -described below), which was recombined onto the chromosome using the recombination genes of bacteriophage l (encoded by D(recC ptr recB recD)::Plac-bet exo kan) (31) . The plasmid pSE250 was made by restriction endonuclease digestion of pSE101 with BamHI at the rhaT' end of the clone and EcoRI (a natural site within the rhaBAD promoter) creating the fragment rhaSRT', which was purified from an agarose gel using Qiagen's QIAEX Gel Extraction Kit. The rhaSRT' fragment was then ligated to pUC18 (46) which had been digested with BamHI and EcoRI. To make pSE254, long-way around PCR using pSE250 as template and primers 2297 and 2298 amplified all of the pSE250 sequence except rhaSR and added a BglII site at each end. Then PCR with primers 2299 and 2300, using a PCR product containing the cat-sac cassette (provided by Kenan Murphy (32) ) as template, generated a product that was ligated to the BglII sites of the long-way around PCR product to create pSE254. Plasmids pML148-169 (containing mutations in the rpoD gene) were obtained from the laboratory of Carol Gross and were sequenced to ensure they still carried the expected mutations. Several of the rpoD alleles were initially found to be wild-type. Assays involving these alleles were repeated upon obtaining true mutants.
Mutagenesis of rhaS and rhaR. The mutant rhaS D250A allele was moved from pSE172 into the context of pSE101 by digesting pSE172 with BstEII and BglII (both sites are native to the wild-type rhaS gene) to create a fragment encoding the RhaS D250A substitution. This fragment was then ligated to similarly digested pSE101 to make pSE249. Genes encoding alanine substitution derivatives of RhaR D276A and RhaR D285A were constructed by oligonucleotide-directed mutagenesis of rhaR in pGEM-11Zf(+) (Promega; Madison, WI) using the GeneEditor kit (Promega) and oligonucleotides 2208 and 2210. The mutant rhaR alleles were then subcloned to pSE250 using NheI and SmaI restriction endonuclease sites (both sites occur naturally within rhaR) to make pSE251 and pSE253. The rhaR E284A mutagenesis was performed using PCR to make oligonucleotide-directed mutations at the desired position with primer 2381, which also contained the recognition sequence for the EarI restriction endonuclease. Second, a non-mutagenized PCR fragment was made, also using a primer with EarI restriction sites. Finally, ligation of the mutant and wild-type DNA fragments allowed seamless reconstruction (25) of the full-length rhaR E284A gene in the context of rhaSRT' to make pSE252. Oligos Etc (Wilsonville, OR), Integrated DNA Technologies (Coralville, IA), and MWG-Biotech (High Point, NC) synthesized oligonucleotide primers used in mutagenesis (Table 2) . Mutations were initially identified by diagnostic PCR using the following method. The very 3' nucleotides of the diagnostic oligonucleotide contained the desired substitution(s) such that amplification was only possible (in combination with a suitable downstream primer) when the template DNA carried the desired mutation. Putative mutants identified by this method were confirmed by DNA sequencing of both strands of the entire cloned region (see Table 2 for sequencing oligonucleotides).
Recombination of rhaS and rhaR alleles onto the chromosome. The mutant rhaS and rhaR alleles constructed as described above were recombined onto the E. coli chromosome such that they replaced the wild type rhaS or rhaR alleles using the following methods. Each rhaS or rhaR mutant was present on a plasmid in the context of rhaSRT' (pSE249, pSE251, pSE252, and pSE253). Oligonucleotides 1170 and 2292 were used to amplify each mutant rhaSRT' region by high-fidelity PCR. Approximately 500 ng of the rhaSRT' PCR product carrying a mutant allele was used to transform . Since SME2495 and SME2496 both contained P lac -bet exo, which encodes the l phage recombination proteins, the frequency of homologous recombination was much higher in these strains than in wild-type E. coli strains (31) . The transformants were screened by spread plating on media containing Xgal (40mg/ml) and L-rhamnose (0.2%) to identify functional, or partially functional, rhaSR genes that replaced the D(rhaSR) allele. There was no selection for successful recombinants in SME2495, rather we screened for blue colonies amongst a lawn of white colonies. When transforming SME2496, which contains a cat-sacB cassette (32) in place of rhaSR, we selected for the sucrose resistance of cells that had lost the sacB gene (which confers sucrose sensitivity) by homologous recombination. However, due to a significant background of spontaneous sucrose resistant mutants, the transformants were also screened for at least partially functional rhaS or rhaR genes by adding X-gal (40mg/ml) and L-rhamnose (0.2%) to the SacB selection plates. RhaR residues D276, E284, and D285 are important for rhaSR transcription activation. In order to test whether the side chains of RhaR residues D276, E284, and D285 might play a role in transcription activation by RhaR, we constructed alanine substitutions at each of these positions. If the amino acid residues at these positions are required for transcription activation, the alanine substitution should result in a significant decrease in activation of rhaSR transcription. To assay the RhaR derivatives, the mutant rhaR alleles on plasmids were first recombined onto the chromosome such that they replaced the wild-type rhaR gene (see Materials and Methods). The wild-type and mutant rhaR alleles were then assayed for activation of F(rhaS-lacZ)D92 (Fig. 5 ).
The results showed that all three of the alanine substitutions in RhaR were significantly defective, highlighting the importance of the wild-type residues at those positions. The especially large defect of RhaR D285A may be partly due to a role in DNA-binding based on its alignment with D250 in RhaS (Fig. 3) , which makes base-specific contacts with DNA (3 Fig. 4 shows that the only negatively charged RhaS residue that is in close proximity to the positively charged s 70 K593 is RhaS D250, suggesting that these two residues might make a contact. Previous results from our lab showed that RhaS D250A was 12-fold defective for F(rhaB-lacZ)D84 activation, however, they also indicated that this residue participates in a base-specific DNA contact (3). In contrast to other approaches to identify positive control mutants, the genetic loss-of-contact approach does not require that the protein have wild-type DNA-binding capability, hence it has the potential to identify residues that have dual DNA-binding and transcription activation functions.
We therefore used the genetic loss-of-contact approach to test whether RhaS D250 and s 70 K593 might be involved in an interaction. The results (Fig. 6D) (Fig. 4) . The results in this paper (Fig. 2) as well as those from the previous study (4) showed that s 70 K593A and R599A were only defective at truncated rha promoters that did not include the upstream CRP binding sites. This is similar to the findings at several other promoters that require multiple activators, such as araBAD, uhpT and narG (18, 27, 36, 39) . Two possible explanations for this trend are that the second activator increases the total number of interactions such that the relative importance of each individual interaction decreases, or that the second activator creates redundancies in activation that mask the importance of other interactions. A third possibility is that the second activator alters the orientation of the first activator relative to s 70 such that the primary activator is no longer in an ideal position to interaction with s
70
. In the first two models, the activator interaction with s 70 occurs both in the presence and absence of the second activator, but can only be detected in its absence, whereas in the third model, the interaction between the first activator and s 70 only occurs in the absence of the second activator. Further experiments will be needed to distinguish these models. At the rhaSR promoter, the s 70 L595A derivative was unique in that it was defective both in the presence and absence of the second activator, CRP, but it's role in RhaR-mediated transcription activation is not yet known. interaction in which the structure of MarA (38) represented RhaR (Fig. 4) , to identify the only two negatively charged RhaR residues, E284 and D285, that were near s 70 K593.
Specific amino acid contacts between
RhaR E284 and D285 were therefore considered candidates for residues that might interact with s 70 K593. After determining that alanine substitutions at RhaR residues D276, E284, and D285 were all defective for rhaSR activation (Fig. 5 ), we used a genetic loss-of-contact approach to test for specific amino acid interactions between s 70 and RhaR.
To carry out a loss-of-contact analysis, one must first identify defective derivatives of each of the potentially interacting proteins. In the simplest case, the full defect of both of the two interacting residues is due to loss of the interaction -in other words, the only role of the two residues is the interaction. The rationale behind this approach in this simple case is that mutation of one or the other of the interacting residues will eliminate the interaction, therefore, the phenotype of a strain carrying both mutations will be the same as the phenotype of the strains carrying the individual mutations. If one of the residues has a second role in addition to the interaction, then the strain carrying both mutations will have a phenotype that is no worse than the more defective of the strains carrying the two individual mutations. This analysis does not provide conclusive results if both residues have roles in addition to the interaction. It is also expected that the predicted interactions will be allele specific. The majority of combinations of defective derivatives are not expected to identify interacting residues; and in these cases the defects resulting from each of the two mutations will at least be additive.
Using this rationale to interpret our genetic loss-of-contact assays, the results in Fig. 6A (Fig. 6D ). Our molecular model of the RhaS-s 70 interaction shows that s 70 K593 and RhaS D250 are in close proximity, consistent with this result (Fig. 4) However, it is likely that there is a difference in the mechanisms of RhaS and RhaR activation that relates to this difference in the positions of the CRP binding sites.
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